Interleukin4 is a T lymphocyte-and mast cell-derived cytokine with pleiotropic properties with biological effects on a variety of target cells including B and T lymphocytes, macrophages, hematopoietic cells, mast cells, and fibroblasts. In addition to the proliferation effect of IL-4 on fibroblasts, which has been previously described, in this report the chemotactic properties of IL4 for fibroblasts is described. Human recombinant IL4 induced the chemotactic migration ofdermal fibroblasts in vitro in modified Boyden-type chambers at concentrations between 10-12 and 10-11 M. The chemotactic activity ofIL-4 was neutralized by anti-human recombinant IL4 IgG antibodies. Oligopeptides representing the complete deduced amino acid sequence of human IL4 were synthesized by the Merrifield technique and tested for their ability to induce fibroblast chemotaxis. Two peptides representing residues 70-88 and 89-122 induced fibroblast migration. Peptide 70-88 was the more potent of the two causing chemotaxis of fibroblasts at 10-8-10-6 M while peptide 89-129 induced migration at 10-7_10-i M. Although the mechanism by which IL4 and these two peptides induce fibroblast chemotaxis is unknown, each of these three compounds were able to chemotactically desensitize fibroblasts to the chemotactic effects of the other two but not to a structurally unrelated chemotactic cytokine, transforming growth factor fi -1. These studies suggest that IL4 might function in vivo to induce the accumulation of fibroblasts at sites of tissue injury, inflammatory and immune reactions in which T lymphocytes and mast cells participate. (J. Clin. In-
Introduction
IL-4, formerly called B cell stimulatory factor-1, was originally characterized as a costimulant with anti-immunoglobulin antibodies for resting murine B cells, causing them to enter the S-phase of growth (1) . Although other effects of IL-4 on B cells have also been described including stimulation ofexpression of class II antigens and production of IgGl and IgE, it is now apparent that this T cell and mast cell product affects a variety of different target cells; It is a growth factor for normal T cells and T cell lines (1) (2) (3) . IL-4 promotes maturation of myeloid precursors to monocyte-macrophages, synergizes with colonystimulating factors such as granulocyte colony stimulatory factor to promote growth ofgranulocytic colonies, and with erythropoietin to stimulate colony formation by immature and mature erythroid precursors and in establishment of megakaryocytic colonies (4) (5) (6) (7) . IL-4 is synthesized by mast cell lines and acts as a costimulator with IL-3 in promoting growth of mast cells (8, 9) . is capable of activating macrophages, augmenting expression ofclass II antigens, and nonspecific cytotoxicity (7, 10, 11) . It also modulates cytokine gene expression, down regulating both IL-1 a and fp, and TNF a mRNA (12) .
Receptors have been identified not only on hemotopoietic cells such as normal B cells, resting and activated T cells, macrophages, and mast cell tumor lines, but also on fibroblasts (13, 14) . Murine dermal and lung fibroblasts have been reported to proliferate in the presence of murine IL-4 (15) . These observations in fibroblasts prompted us to determine whether could act as a chemoattractant for these cells. In this study, we have observed that human recombinant (hr)IL-4 is indeed a potent chemotactic agent for fibroblasts. Structure-function studies employing synthetic peptides have identified two peptides, 70-88 and 89-122, that are able to induce fibroblast chemotaxis. Furthermore, these peptides can specifically deactivate fibroblasts so that they do not chemotax to hrIL-4 or to each other, suggesting that the fibroblast chemotactic property resides within these amino acid residues of IL-4.
Methods
Fibroblast chemotaxis. Fibroblasts maintained in monolayer cultures and grown from infant foreskin explants were used as indicator cells in chemotaxis studies. Maintenance medium for fibroblast cultures consisted of Eagle's minimum essential medium (Gibco Laboratories, Grand Island, NY) supplemented with 9% fetal bovine serum, nonessential amino acids, 50 ,g/ml ascorbic acid, 100 U/ml penicillin, 100
,gg/ml streptomycin, and 5 gg/ml amphotericin B. All samples were tested in quadruplicate and fibroblast migration was measured as previously described using blind-well Boyden-type chambers equipped with gelatin-treated polycarbonate filters (8 micron pore size; Nucleopore Corp., Pleasanton, CA) (16) . Nuclei (18) . The peptides were purified by gel filtration and reverse phase HPLC, and the amino acid composition ofeach peptide was confirmed by use of a Beckman 121 MB automatic amino acid analyzer (19, 20) .
Results
Chemotaxis offibroblasts to hrIL-4. On numerous occasions using different batches of hrIL-4 and fibroblast lines from different donors, hrIL-4 consistently induced maximal migration of fibroblasts at concentrations ranging between 1 and 50 pg/ ml (7.1 X 10-14-3.6 X 10-12 M). A representative experiment is shown in Fig. 1 . As has been found with other fibroblast chemoattractants, the response curve was bell shaped (21, 22) . To determine whether hrIL-4 was chemotactic, and/or chemokinetic for fibroblasts, a checkerboard analysis of the ZigmondHirsch type was performed wherein different concentrations of hrIL-4 were added to the upper (cell) and lower (test) compartments of the modified blind-well Boyden-type chambers, and migration of fibroblasts was measured (23) . hrIL-4-induced increased migration of fibroblasts when it was present in the lower compartment ofthe chambers relative to the upper compartment (Table I ). This experiment was repeated twice with different cell lines and similar results were obtained (data not shown). This indicates that IL-4 induces chemotaxis rather than chemokinesis of fibroblasts.
Inhibition ofhrIL-4 inducedchemotaxis byanti-hrIL-4 antibodies. Polyclonal rabbit anti-hrIL-4 IgG effectively neutralized the chemotactic property of hrIL-4 but had no effect on the chemotactic activity of TGF-#3I (Table II) Figure 1 . hrIL-4 was tested at the concentrations indicated for its ability to induce fibroblast migration. (Tables IV and V) . Chemotaxis desensitization studies. Chemoattractant or receptor specific desensitization has been demonstrated for chemotaxins for neutrophils and fibroblasts (24) (25) (26) . To determine whether IL-4-specific desensitization could be achieved by peptide 70-88 and/or 89-122 and vice versa, experiments were performed in which the fibroblasts in the upper compartments were exposed to chemotactic levels ofeither hrIL-4, peptide 70-88, peptide 89-122, or to media, and their subsequent migration to these chemoattractants and an unrelated cytokine, TGF-,lB, was assessed. The migration of fibroblasts to (Table VI) . Similar results were obtained when this experiment was repeated (data not shown).
These results suggest that these synthetic peptides mediate fibroblast chemotaxis by a mechanism (or perhaps receptor) similar to that used by hrIL-4.
Discussion
Fibroblast migration was stimulated in vitro by hrIL-4 at concentrations ranging between 10-12 and 10-" M. Increased mi- tissue (27, 28) . The observation that IL-4 is a potent inducer of fibroblast chemotaxis in vitro suggests that it could play a role in the recruitment of fibroblasts in vivo to sites oftissue injury. IL-4 could be released from mast cells and/or T lymphocytes at sites of inflammation and promote fibrogenesis. Mast cells are associated with a variety of human diseases characterized by excessive fibroblast accumulation and fibrosis including chronic inflammatory states such as parasitic diseases, rheumatoid arthritis synovium, psoriasis, interstitial pulmonary fibrosis, various tumors including carcinoids, keloids, hemangiomas, neurofibromas, mastocytosis, scleroderma, and scleroderma-like conditions such as toxic oil syndrome, chronic graft versus host disease, and eosinophilic fasciitis (see reference 29 for review).
IL-4 could also be released from T lymphocytes participating in immune and inflammatory reactions in vivo. Several conditions such as the early lesions of scleroderma, chronic graft versus host disease, streptococcal cell wall induced granulomatous inflammation in rats, granulomas associated with tuberculosis, and sarcoidosis have prominent infiltration of f lymphocytes (29) (30) (31) (32) (33) . Perhaps the multinucleated giant cells associated with the latter three conditions also develop in part from IL4, which is also known to promote monocyte polykaryon formation (34) .
The mechanism(s) by which IL-4 induces fibroblast chemotaxis is unknown. Presumably it is effecting migration via an IL-4 receptor (IL-4R)-dependent or related mechanism. IL4Rs have been described on fibroblasts as well as a variety of hematopoietic cells (13, 14) . The IL4R on human gingival fibroblasts and Raji B cells has an observed mol wt of 139,000 (14) . The human IL-4R cDNA has been recently isolated and when transfected into COS-7 cells, was shown to encode a 140,000 mol wt protein (35) . The predicted extracellular domain of the human IL-4R has a high degree of amino acid sequence homology with receptors for interleukin-6, erythropoietin and prolactin, and with the (3 subunit ofthe IL-2R (35 (16, 21, 22, 25, (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) . This would imply that stimulated T lymphocytes have the capacity to synthesize and release at least three different cytokine-lymphokine agents (TGF-fl, interferon y, and IL-4) to promote the accumulation of fibroblasts in vivo.
The synthetic IL-4 peptides 70-88 and 89-122 were much less potent than hrIL-4 in inducing fibroblast chemotaxis. Synthetic human IL-1(3 peptides have been reported to have less potent biological effects than hrIL-1,B, and a biologically active synthetic growth hormone peptide has been reported to be less potent than intact growth hormone (46) (47) (48) . This reduced potency of synthetic cytokine oligopeptides may be due to their small size and absence of other sequences required for optimal receptor binding.
There is 50% homology between inferred amino acid sequences of human and murine IL-4, however, murine IL4 does not stimulate human cells, and human LA does not stimulate murine cells (17, 49) . It is not apparent why the chemotactic property of human IL4 resides in residues 70-88 and 89-122. It is interesting and perhaps significant that the most potent chemotactic peptide (70-88) has the most amino acid homology (58%) with its murine IL-4 counterpart (calculated from sequences shown in reference 17 for murine and human IL-4). However, peptide 89-122, which was 10-fold less potent, has the least amino acid homology with its murine IL4 counterpart (29%) than any of the six IL-4 peptides studied. Whether either of these peptides are involved in IL-4 receptor binding remains to be established. This report characterizes another formerly unrecognized property of IL-4, namely, its ability to induce fibroblast migration. It is interesting to speculate that the fibrogenic reaction characterized by accumulation of fibroblasts and matrix components at sites of immune and inflammatory reactions in which T cells and/or mast cells play a prominent role may be due in part to the stimulation ofchemotaxis and replication of fibroblasts by IL4. Future work dealing with the mechanisms by which a fibrogenic response accompanies certain T lymphocyte-and mast cell-mediated immune and inflammatory reactions should assess the possible participation of IL4.
